Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

VYM vs XBI: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, VYM returned +18.0% to XBI's +41.2%, and VYM charges 0.04% to XBI's 0.35%.

askIQ about this page

askIQ about VYM and XBI

Net assets: $78.9bn on Sep 30, 2026 for Vanguard High Dividend Yield ETF, and $10.3bn on Oct 27, 2026 for State Street SPDR S&P Biotech ETF.

At a glance
+18.0%
VYM total return, 1 year
+41.2%
XBI total return, 1 year
0.04%
VYM expense ratio
0.35%
XBI expense ratio

Pair scorecard

VYM costs 0.31 points a year less; their one-year returns differ by 23.2 points; VYM is 7.6 times larger.

VYM vs XBI: Differences, Returns & Fees
MeasureVYMXBI
Return
Total return, 1 year+18.0%+41.2%
Drawdown
Below its all-time high8.9%, high on Feb 8, 2021
Benchmark
What it tracksFTSE High Dividend Yield IndexBiotech
Cost and size
Expense ratio0.04%0.35%
Net assets, as of Sep 30, 2026$78.9bn$10.4bn
Active share vs the S&P 50098%
Holdings
Holdings in common3%
Top ten holdings, share of the fund26.2%18%

Holdings in common uses holdings dated Sep 30, 2026 and Oct 27, 2026. Method

Risk and return

Nov 24, 2006 to Oct 23, 2026 · 1,039 weekly returns
VYM XBI
Return
Total return edge XBI +487.1% +822.8%
Annualized edge XBI +9.3% +11.8%
Price return edge XBI +220.2% +772.5%
Risk
Volatility edge VYM 16.7% 29.5%
Max drawdown edge VYM (slight) −56.7% −61.5%
Risk-adjusted
Sharpe edge VYM (slight) 0.52 0.47
Sortino edge VYM (slight) 0.73 0.69
Calmar edge XBI 0.16 0.19
Reading

XBI returned more: +822.8% to +487.1%. VYM swung less: 16.7% to 29.5%. VYM fell slightly less at its worst: −56.7% to −61.5%.

Full scorecard

9 measures, with how each is measured
Open ↓
Risk and return: VYM vs XBI: Differences, Returns & Fees
MeasureVYMXBIEdgeHow it is measured
Return
Total return+487.1%+822.8%XBIPrice change plus distributions, reinvested.
Annualized+9.3%+11.8%XBITotal return as a yearly rate.
Price return+220.2%+772.5%XBIPrice change alone, distributions left out.
Risk
Volatility16.7%29.5%VYMSpread of weekly returns, annualized. Lower is steadier.
Downside deviation11.8%20.1%VYMLike volatility, counting only weeks below the Treasury bill rate.
Max drawdown−56.7%−61.5%VYM (slight)Deepest fall from a high to the low after it.
Risk-adjusted
Sharpe0.520.47VYM (slight)Return above Treasury bills per unit of volatility.
Sortino0.730.69VYM (slight)Return above Treasury bills per unit of downside deviation.
Calmar0.160.19XBIAnnualized return divided by the max drawdown.

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 1,039 weekly returns. Cash rate: the 13-week Treasury bill.

What they share

3%

By the books each fund has filed, VYM and XBI hold 3% of their money in the same securities at the same weight. Holdings dated Sep 30, 2026 and Oct 27, 2026.

0 half 100%

half

3% in common

Positions both hold · largest shared weight first VYM XBI
AbbVie Inc 1.96% 1.67%
Amgen Inc 0.89% 1.68%
Gilead Sciences Inc 0.79% 1.60%
Only in one fund ↓
Only in VYM
Broadcom Inc 6.93%
JPMorgan Chase & Co 3.75%
ExxonMobil Holdings Corp 2.84%
Johnson & Johnson 2.71%
Cisco Systems Inc 1.80%
Chevron Corp 1.61%
Caterpillar Inc 1.56%
Merck & Co Inc 1.52%
Only in XBI
MODERNA INC 2.24%
TWIST BIOSCIENCE CORP 1.86%
NATERA INC 1.82%
BIOGEN INC 1.75%
HALOZYME THERAPEUTICS INC 1.75%
UNITED THERAPEUTICS CORP 1.71%
SPYRE THERAPEUTICS INC 1.67%
EXELIXIS INC 1.64%
Check overlap with more funds →

Side by side

VYM Vanguard High Dividend Yield ETF XBI State Street SPDR S&P Biotech ETF
Where it sits Stock ETF Thematic ETF
What it is Tracks an index of US high dividend Biotech
Total return, 1 year +18.0% +41.2%
Expense ratio 0.04% 0.35%
Already in the S&P 500 89.5% 13.2%
Holdings 595 165
Net assets, VYM as of Sep 30, 2026 and XBI as of Oct 27, 2026 $78.9bn $10.3bn

VYM and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Client brief · page 1 of 2 Report BR-BF976292C7

VYM and XBI do different jobs. What does each one do in a portfolio?

  1. What each follows. VYM follows FTSE High Dividend Yield Index and XBI follows Biotech.
  2. Holdings in common. 3% of the weight is in the same securities (holdings dated Sep 30, 2026 and Oct 27, 2026).
  3. One-year total return. Over 1 year to Oct 28, 2026 VYM returned +18.0% and XBI +41.2% with distributions reinvested, a gap of 23.2 points.

Data as of Oct 28, 2026.

The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.

Your saved page · Privacy.

Alert

XBI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
VYM

VYM tracks an index of US high dividend. Over the year to Oct 28, 2026 it returned +18.0% with distributions reinvested. The prospectus expense ratio is 0.04% a year. By its holdings published by its issuer as of Sep 30, 2026, 90% of the fund by weight is stocks the S&P 500 also holds, across 595 positions, with the top ten at 26.2%.

XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

Questions people ask

Are VYM and XBI in the same category?
VYM is a stock ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, VYM or XBI?
In the year to Oct 28, 2026, with distributions reinvested, VYM returned +18.0% and XBI +41.2%.
Which is cheaper, VYM or XBI?
VYM is cheaper, by 0.31 percentage points a year. That is about $31 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do VYM and XBI overlap with the S&P 500?
By their latest filed holdings, 90% of VYM and 13% of XBI by weight is stocks the S&P 500 already holds.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, VYM against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/vym-vs-xbi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.